chronic kidney disease
Conditions
Interventions
None listed
Sponsors
Division of Nephrology and Hypertension, Osaka City General Hospital
Department of Pharmacology, Faculty of Medicine, Kagawa University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: patients with chronic renal disease
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| immunoreactivity for desmin, N-type calcium channel, Wilms' tumor factor 1, and podocin in renal biopsy specimens mRNA expression of desmin, N-type calcium channel, podocin,nephrin in renal biopsy specimens urinary excretion of protein systemic blood pressure | — |
Secondary
| Measure | Time frame |
|---|---|
| blood urea nitrogen, serum creatinine, effective renal plasma flow, creatinine clearance, filtration fraction, urinary excretion of angiotensinogen | — |
Countries
Japan
Contacts
Public ContactYoshio Konishi
Osaka City General Hospital Nephrology and Hypertension
Outcome results
None listed